<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 43-year-old man with oligoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and t(3;8) variant translocation is reported </plain></SENT>
<SENT sid="1" pm="."><plain>At first he was classified as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation according to the FAB criteria for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Remission was obtained after intensive chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>After 8 months, a relapse occurred as overt M2 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>At presentation chromosome study of bone marrow cells using R- and G-bandings revealed 45,X, -Y,t(3;8)(q29;q22) in 35 of the 42 metaphases analyzed and 46,XY,t(3;8) in one metaphase in addition to <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype in the other six metaphases </plain></SENT>
<SENT sid="5" pm="."><plain>However, RT-PCR assay showed no AML1/<z:chebi fb="0" ids="27561">ETO</z:chebi> fusion transcript </plain></SENT>
<SENT sid="6" pm="."><plain>At relapse, a karyotype of 46, XY,t(3;8), deletion(4)(p14), add(7)(q32) was observed in <z:hpo ids='HP_0000001'>all</z:hpo> abnormal cells indicating a clonal karyotypic evolution </plain></SENT>
<SENT sid="7" pm="."><plain>We believed that this case should be diagnosed as an early form of M2 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> initially </plain></SENT>
<SENT sid="8" pm="."><plain>It may be the first case of oligoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> with t(3;8) variant translocation </plain></SENT>
<SENT sid="9" pm="."><plain>Further study is needed to elucidate its <z:chebi fb="0" ids="23367">molecular entity</z:chebi> </plain></SENT>
</text></document>